A Cancer Antigen Long Thought Untouchable Is Suddenly the Hottest Target in Oncology Life Science Investing
Republic Technologies Enters Strategic Software Licensing Partnership with Sign Foundation Medical Device Investing
Tarsus and John Cena Partner to Raise Awareness of Demodex blepharitis, a Common Eyelid Disease Affecting Approximately 25 Million Americans Life Science Investing
Candel Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Highlights Life Science Investing
Corbus Pharmaceuticals Appoints Pharma Industry Veteran Brent Pfeiffenberger to Board of Directors Life Science Investing
The Radoff-JEC Group Submits its Third Non-Binding Proposal to Acquire Seer, Inc. Life Science Investing
Chemomab Therapeutics Announces First Quarter 2026 Financial Results and Provides Corporate Update Life Science Investing
Benitec Biopharma Releases Third Quarter 2026 Financial Results and Provides Operational Update Life Science Investing
Nuvectis Pharma, Inc. To Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ Life Science Investing
HCW Biologics Discovers that HCW11-040 Prevents Bronchopulmonary Dysplasia During IND-Enabling Studies Life Science Investing
MiNK Therapeutics and First Lviv Territorial Medical Union Initiate Randomized Phase 2 Trial of agenT-797 in Acute Lung Injury and Critical Illness Life Science Investing
BriaCell Completes Manufacturing of Clinical Supplies of Bria-PROS+ for Prostate Cancer Biotech Investing
BriaCell Receives Positive Recommendation from Data Safety Monitoring Board for Phase 3 Study in Metastatic Breast Cancer
